Radiation takes its Toll

Cancer Letters

Volumn 368, Issue 2, 2015, Pages 238-245

  Ratikan, Josephine A ^a   Micewicz, Ewa D ^a   Xie, Michael W ^a   Schaue, Dörthe ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Inflammation; Radiation; Reactive oxygen species; Redox; Toll like receptors

Indexed keywords

DAMAGE ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; REACTIVE OXYGEN METABOLITE;

CANCER RADIOTHERAPY; CELL INTERACTION; HUMAN; INNATE IMMUNITY; IONIZING RADIATION; NONHUMAN; OXIDATION REDUCTION STATE; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIATION EXPOSURE; RADIATION INJURY; RECEPTOR UPREGULATION; SHORT SURVEY; SIGNAL TRANSDUCTION; TISSUE INJURY; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; RADIATION RESPONSE;

HUMANS; IMMUNE SYSTEM; INFLAMMATION; RADIATION INJURIES; REACTIVE OXYGEN SPECIES; TOLL-LIKE RECEPTORS;

EID: 84941874517     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.03.031     Document Type: Review

References (134)

1. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397. pmid:9237759.
2. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol 1989, 54(Pt 1):1-13. pmid:2700931.
3. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305. pmid:11951032.
4. Medzhitov R. Approaching the asymptote: 20 years later. Immunity 2009, 30:766-775. pmid:19538928.
5. Curtin J.F., Liu N., Candolfi M., Xiong W., Assi H., Yagiz K., et al. HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med 2009, 6. e10. pmid:19143470.
6. Lotze M.T., Zeh H.J., Rubartelli A., Sparvero L.J., Amoscato A.A., Washburn N.R., et al. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol. Rev 2007, 220:60-81. pmid:17979840.
7. Sato Y., Goto Y., Narita N., Hoon D.S. Cancer cells expressing toll-like receptors and the tumor microenvironment. Cancer Microenviron 2009, 2(Suppl. 1):205-214. pmid:19685283.
8. Shi Y., Evans J.E., Rock K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003, 425:516-521. pmid:14520412.
9. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650. pmid:21616434.
10. Menendez D., Shatz M., Azzam K., Garantziotis S., Fessler M.B., Resnick M.A. The Toll-like receptor gene family is integrated into human DNA damage and p53 networks. PLoS Genet 2011, 7. e1001360. pmid:21483755.
11. Hehrlein C., Kaiser S., Riessen R., Metz J., Fritz P., Kubler W. External beam radiation after stent implantation increases neointimal hyperplasia by augmenting smooth muscle cell proliferation and extracellular matrix accumulation. J. Am. Coll. Cardiol 1999, 34:561-566. pmid:10440173.
12. Chang C.T., Lin H., Ho T.Y., Li C.C., Lo H.Y., Wu S.L., et al. Comprehensive assessment of host responses to ionizing radiation by nuclear factor-kappaB bioluminescence imaging-guided transcriptomic analysis. PLoS ONE 2011, 6. e23682. pmid:21887294.
13. Iwakawa M., Noda S., Ohta T., Oohira C., Tanaka H., Tsuji A., et al. Strain dependent differences in a histological study of CD44 and collagen fibers with an expression analysis of inflammatory response-related genes in irradiated murine lung. J. Radiat. Res 2004, 45:423-433. pmid:15613788.
14. Takemura N., Kawasaki T., Kunisawa J., Sato S., Lamichhane A., Kobiyama K., et al. Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome. Nat. Commun 2014, 5:3492. pmid:24637670.
15. Shan Y.X., Jin S.Z., Liu X.D., Liu Y., Liu S.Z. Ionizing radiation stimulates secretion of pro-inflammatory cytokines: dose-response relationship, mechanisms and implications. Radiat. Environ. Biophys 2007, 46:21-29. pmid:17072632.
16. El-Saghire H., Michaux A., Thierens H., Baatout S. Low doses of ionizing radiation induce immune-stimulatory responses in isolated human primary monocytes. Int. J. Mol. Med 2013, 32:1407-1414. pmid:24085242.
17. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med 2007, 13:1050-1059. pmid:17704786.
18. Stangl S., Themelis G., Friedrich L., Ntziachristos V., Sarantopoulos A., Molls M., et al. Detection of irradiation-induced, membrane heat shock protein 70 (Hsp70) in mouse tumors using Hsp70 Fab fragment. Radiother. Oncol 2011, 99:313-316. pmid:21704400.
19. Goltry K.L., Epperly M.W., Greenberger J.S. Induction of serum amyloid A inflammatory response genes in irradiated bone marrow cells. Radiat. Res 1998, 149:570-578. pmid:9611095.
20. Feurgard C., Boehler N., Ferezou J., Serougne C., Aigueperse J., Gourmelon P., et al. Ionizing radiation alters hepatic cholesterol metabolism and plasma lipoproteins in Syrian hamster. Int. J. Radiat. Biol 1999, 75:757-766. pmid:10405006.
21. Lee Y.S., Sohn K.C., Jang S., Lee Y., Hwang C., Kim K.H., et al. Anti-apoptotic role of S100A8 in X-ray irradiated keratinocytes. J. Dermatol. Sci 2008, 51:11-18. pmid:18325741.
22. Chaudhry M.A. Radiation-induced gene expression profile of human cells deficient in 8-hydroxy-2'-deoxyguanine glycosylase. Int. J. Cancer 2006, 118:633-642. pmid:16106417.
23. Gordeeva K.V. On the relation between fibrinogenase activity and raised fibrinogen concentrations in dogs during radiation sickeness. Biull. Eksp. Biol. Med 1962, 54:39-42. pmid:13949173.
24. Magic Z., Matic-Ivanovic S., Savic J., Poznanovic G. Ionizing radiation-induced expression of the genes associated with the acute response to injury in the rat. Radiat. Res 1995, 143:187-193. pmid:7543208.
25. Nylund R., Lemola E., Hartwig S., Lehr S., Acheva A., Jahns J., et al. Profiling of low molecular weight proteins in plasma from locally irradiated individuals. J. Radiat. Res 2014, 55:674-682. pmid:24570173.
26. Riekki R., Jukkola A., Oikarinen A., Kallioinen M. Radiation therapy induces tenascin expression and angiogenesis in human skin. Acta Derm. Venereol 2001, 81:329-333. pmid:11800138.
27. Geffrotin C., Tricaud Y., Crechet F., Castelli M., Lefaix J.L., Vaiman M. Unlike tenascin-X, tenascin-C is highly up-regulated in pig cutaneous and underlying muscle tissue developing fibrosis after necrosis induced by very high-dose gamma radiation. Radiat. Res 1998, 149:472-481. pmid:9588358.
28. Wehrhan F., Rodel F., Grabenbauer G.G., Amann K., Bruckl W., Schultze-Mosgau S. Transforming growth factor beta 1 dependent regulation of Tenascin-C in radiation impaired wound healing. Radiother. Oncol 2004, 72:297-303. pmid:15450728.
29. Zhang M., Zhang B., Guo Y., Zhang L., Yang S., Yin L., et al. Alteration of circulating mitochondrial DNA concentration after irradiation. Adv. Exp. Med. Biol 2013, 765:371-377. pmid:22879058.
30. Kanzler H., Barrat F.J., Hessel E.M., Coffman R.L. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat. Med 2007, 13:552-559. pmid:17479101.
31. Rakoff-Nahoum S., Medzhitov R. Toll-like receptors and cancer. Nat. Rev. Cancer 2009, 9:57-63. pmid:19052556.
32. O'Neill L.A., Golenbock D., Bowie A.G. The history of Toll-like receptors - redefining innate immunity. Nat. Rev. Immunol 2013, 13:453-460. pmid:23681101.
33. Piccinini A.M., Midwood K.S. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010, 2010:1-21. pmid:20706656.
34. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252. pmid:9521319.
35. Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med 1999, 5:1249-1255. pmid:10545990.
36. Nair-Gupta P., Baccarini A., Tung N., Seyffer F., Florey O., Huang Y., et al. TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation. Cell 2014, 158:506-521. pmid:25083866.
37. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol 2003, 21:685-711. pmid:12615891.
38. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest 2012, 122:787-795. pmid:22378047.
39. Cario E., Podolsky D.K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun 2000, 68:7010-7017. pmid:11083826.
40. Fitzner N., Clauberg S., Essmann F., Liebmann J., Kolb-Bachofen V. Human skin endothelial cells can express all 10 TLR genes and respond to respective ligands. Clin. Vaccine Immunol 2008, 15:138-146. pmid:17978010.
41. Schaue D., McBride W.H. Links between innate immunity and normal tissue radiobiology. Radiat. Res 2010, 173:406-417. pmid:20334512.
42. Schaue D., Kachikwu E.L., McBride W.H. Cytokines in radiobiological responses: a review. Radiat. Res 2012, 178:505-523. pmid:23106210.
43. Jones G.R. Free radicals in immunological killing: the case of tumor necrotising factor (TNF). Med. Hypotheses 1986, 21:267-271. pmid:3642198.
44. Watanabe N., Niitsu Y., Neda H., Sone H., Yamauchi N., Maeda M., et al. Cytocidal mechanism of TNF: effects of lysosomal enzyme and hydroxyl radical inhibitors on cytotoxicity. Immunopharmacol. Immunotoxicol 1988, 10:109-116. pmid:2834428.
45. Bubici C., Papa S., Dean K., Franzoso G. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 2006, 25:6731-6748. pmid:17072325.
46. Yang D., Elner S.G., Bian Z.M., Till G.O., Petty H.R., Elner V.M. Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells. Exp. Eye Res 2007, 85:462-472. pmid:17765224.
47. Xiang M., Fan J. Association of Toll-like receptor signaling and reactive oxygen species: a potential therapeutic target for posttrauma acute lung injury. Mediators Inflamm 2010, 2010. pmid:20706658.
48. Fan J., Li Y., Levy R.M., Fan J.J., Hackam D.J., Vodovotz Y., et al. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J. Immunol 2007, 178:6573-6580. pmid:17475888.
49. Fan J., Kapus A., Marsden P.A., Li Y.H., Oreopoulos G., Marshall J.C., et al. Regulation of Toll-like receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharide. J. Immunol 2002, 168:5252-5259. pmid:11994482.
50. McBride W.H., Chiang C.S., Olson J.L., Wang C.C., Hong J.H., Pajonk F., et al. A sense of danger from radiation. Radiat. Res 2004, 162:1-19. pmid:15222781.
51. Perez C.A., Fu A., Onishko H., Hallahan D.E., Geng L. Radiation induces an antitumour immune response to mouse melanoma. Int. J. Radiat. Biol 2009, 85:1126-1136. pmid:19995238.
52. Golden E.B., Frances D., Pellicciotta I., Demaria S., Helen Barcellos-Hoff M., Formenti S.C. Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. Oncoimmunology 2014, 3. e28518. pmid:25071979.
53. Tang D., Kang R., Zeh H.J., Lotze M.T. High-mobility group box 1, oxidative stress, and disease. Antioxid. Redox Signal 2011, 14:1315-1335. pmid:20969478.
54. Tsukimoto M., Homma T., Ohshima Y., Kojima S. Involvement of purinergic signaling in cellular response to gamma radiation. Radiat. Res 2010, 173:298-309. pmid:20199215.
55. Rubner Y., Muth C., Strnad A., Derer A., Sieber R., Buslei R., et al. Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines. Radiat. Oncol 2014, 9(89). pmid:24678590.
56. Schmid T.E., Multhoff G. Radiation-induced stress proteins - the role of heat shock proteins (HSP) in anti- tumor responses. Curr. Med. Chem 2012, 19:1765-1770. pmid:22414085.
57. Obeid M., Panaretakis T., Joza N., Tufi R., Tesniere A., van Endert P., et al. Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis. Cell Death Differ 2007, 14:1848-1850. pmid:17657249.
58. Oka T., Hikoso S., Yamaguchi O., Taneike M., Takeda T., Tamai T., et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 2012, 485:251-255. pmid:22535248.
59. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002, 416:603-607. pmid:11948342.
60. Muruve D.A., Petrilli V., Zaiss A.K., White L.R., Clark S.A., Ross P.J., et al. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 2008, 452:103-107. pmid:18288107.
61. Bauernfeind F.G., Horvath G., Stutz A., Alnemri E.S., MacDonald K., Speert D., et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol 2009, 183:787-791. pmid:19570822.
62. Stoecklein V.M., Osuka A., Ishikawa S., Lederer M.R., Wanke-Jellinek L., Lederer J.A. Radiation exposure induces inflammasome pathway activation in immune cells. J. Immunol 2015, 194:1178-1189. pmid:25539818.
63. Chiang C.S., Hong J.H., Stalder A., Sun J.R., Withers H.R., McBride W.H. Delayed molecular responses to brain irradiation. Int. J. Radiat. Biol 1997, 72:45-53. pmid:9246193.
64. Chiang C.S., Liu W.C., Jung S.M., Chen F.H., Wu C.R., McBride W.H., et al. Compartmental responses after thoracic irradiation of mice: strain differences. Int. J. Radiat. Oncol. Biol. Phys 2005, 62:862-871. pmid:15936571.
65. Ohshima Y., Tsukimoto M., Takenouchi T., Harada H., Suzuki A., Sato M., et al. gamma-Irradiation induces P2X(7) receptor-dependent ATP release from B16 melanoma cells. Biochim. Biophys. Acta 2010, 1800:40-46. pmid:19854240.
66. Nishimaki N., Tsukimoto M., Kitami A., Kojima S. Autocrine regulation of gamma-irradiation-induced DNA damage response via extracellular nucleotides-mediated activation of P2Y6 and P2Y12 receptors. DNA Repair (Amst) 2012, 11:657-665. pmid:22682873.
67. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107. pmid:20203610.
68. Miller Y.I., Choi S.H., Wiesner P., Fang L., Harkewicz R., Hartvigsen K., et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ. Res 2011, 108:235-248. pmid:21252151.
69. Kazama H., Ricci J.E., Herndon J.M., Hoppe G., Green D.R., Ferguson T.A. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008, 29:21-32. pmid:18631454.
70. Inoue H., Tani K. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments. Cell Death Differ 2014, 21:39-49. pmid:23832118.
71. Gasser S., Orsulic S., Brown E.J., Raulet D.H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005, 436:1186-1190. pmid:15995699.
72. Kim K.W., Kim S.H., Shin J.G., Kim G.S., Son Y.O., Park S.W., et al. Direct injection of immature dendritic cells into irradiated tumor induces efficient antitumor immunity. Int. J. Cancer 2004, 109:685-690. pmid:14999775.
73. Taura M., Eguma A., Suico M.A., Shuto T., Koga T., Komatsu K., et al. p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines. Mol. Cell. Biol 2008, 28:6557-6567. pmid:18779317.
74. Ermolaeva M.A., Segref A., Dakhovnik A., Ou H.L., Schneider J.I., Utermohlen O., et al. DNA damage in germ cells induces an innate immune response that triggers systemic stress resistance. Nature 2013, 501:416-420. pmid:23975097.
75. Chovatiya R., Medzhitov R. Honor thy Go(na)ds. Immunol. Cell Biol 2013, 91:597-598. pmid:24060964.
76. Schaue D., Micewicz E.D., Ratikan J.A., Xie M.W., Cheng G., McBride W.H. Radiation and inflammation. Semin. Radiat. Oncol 2015, 25:4-10. pmid:25481260.
77. McDonald J.T., Kim K., Norris A.J., Vlashi E., Phillips T.M., Lagadec C., et al. Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res 2010, 70:8886-8895. pmid:20940400.
78. Smith J.T., Willey N.J., Hancock J.T. Low dose ionizing radiation produces too few reactive oxygen species to directly affect antioxidant concentrations in cells. Biol. Lett 2012, 8:594-597. pmid:22496076.
79. Hong J.H., Chiang C.S., Campbell I.L., Sun J.R., Withers H.R., McBride W.H. Induction of acute phase gene expression by brain irradiation. Int. J. Radiat. Oncol. Biol. Phys 1995, 33:619-626. pmid:7558951.
80. Rodel F., Frey B., Gaipl U., Keilholz L., Fournier C., Manda K., et al. Modulation of inflammatory immune reactions by low-dose ionizing radiation: molecular mechanisms and clinical application. Curr. Med. Chem 2012, 19:1741-1750. pmid:22414082.
81. Kalm M., Roughton K., Blomgren K. Lipopolysaccharide sensitized male and female juvenile brains to ionizing radiation. Cell Death Dis 2013, 4. e962. pmid:24336082.
82. Chen H., Wang Z.D., Chen M.S., Zhang X.Q., Shen L.P., Zhang J.X., et al. Activation of Toll-like receptors by intestinal microflora reduces radiation-induced DNA damage in mice. Mutat. Res. Genet. Toxicol. Environ. Mutagen 2014, 774:22-28. pmid:25440907.
83. Saha S., Bhanja P., Liu L., Alfieri A.A., Yu D., Kandimalla E.R., et al. TLR9 agonist protects mice from radiation-induced gastrointestinal syndrome. PLoS ONE 2012, 7. e29357. pmid:22238604.
84. Ando K., Hasegawa K., Shindo K., Furusawa T., Fujino T., Kikugawa K., et al. Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling. FEBS J. 2010, 277:2051-2066. pmid:20345905.
85. Puddu P., Latorre D., Carollo M., Catizone A., Ricci G., Valenti P., et al. Bovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cells. PLoS ONE 2011, 6. e22504. pmid:21799877.
86. Zheng Y., Qin Z., Ye Q., Chen P., Wang Z., Yan Q., et al. Lactoferrin suppresses the Epstein-Barr virus-induced inflammatory response by interfering with pattern recognition of TLR2 and TLR9. Lab. Invest 2014, 94:1188-1199. pmid:25068657.
87. Paulos C.M., Wrzesinski C., Kaiser A., Hinrichs C.S., Chieppa M., Cassard L., et al. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J. Clin. Invest 2007, 117:2197-2204. pmid:17657310.
88. Lorimore S.A., Coates P.J., Scobie G.E., Milne G., Wright E.G. Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects?. Oncogene 2001, 20:7085-7095. pmid:11704832.
89. Ochi A., Graffeo C.S., Zambirinis C.P., Rehman A., Hackman M., Fallon N., et al. Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. J. Clin. Invest 2012, 122:4118-4129. pmid:23023703.
90. Salcedo R., Cataisson C., Hasan U., Yuspa S.H., Trinchieri G. MyD88 and its divergent toll in carcinogenesis. Trends Immunol 2013, 34:379-389. pmid:23660392.
91. McAllister K.A., Lorimore S.A., Wright E.G., Coates P.J. In vivo interactions between ionizing radiation, inflammation and chemical carcinogens identified by increased DNA damage responses. Radiat. Res 2012, 177:584-593. pmid:22463680.
92. Trott K.R., Rosemann M. Molecular mechanisms of radiation carcinogenesis and the linear, non-threshold dose response model of radiation risk estimation. Radiat. Environ. Biophys 2000, 39:79-87. pmid:10929376.
93. Morgan W.F., Sowa M.B. Non-targeted effects induced by ionizing radiation: mechanisms and potential impact on radiation induced health effects. Cancer Lett 2013, 356:17-21. pmid:24041870.
94. Lozupone C.A., Stombaugh J.I., Gordon J.I., Jansson J.K., Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012, 489:220-230. pmid:22972295.
95. Nejdfors P., Ekelund M., Westrom B.R., Willen R., Jeppsson B. Intestinal permeability in humans is increased after radiation therapy. Dis. Colon Rectum 2000, 43:1582-1587. discussion 1587-1588. pmid:11089597.
96. Santaolalla R., Abreu M.T. Innate immunity in the small intestine. Curr. Opin. Gastroenterol 2012, 28:124-129. pmid:22241076.
97. Liu C., Zhang C., Mitchel R.E., Cui J., Lin J., Yang Y., et al. A critical role of toll-like receptor 4 (TLR4) and its' in vivo ligands in basal radio-resistance. Cell Death Dis 2013, 4:e649. pmid:23722538.
98. Crawford P.A., Gordon J.I. Microbial regulation of intestinal radiosensitivity. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:13254-13259. pmid:16129828.
99. Smith W.W., Alderman I.M., Gillespie R.E. Increased survival in irradiated animals treated with bacterial endotoxins. Am. J. Physiol 1957, 191:124-130. pmid:13478698.
100. Vijay-Kumar M., Aitken J.D., Sanders C.J., Frias A., Sloane V.M., Xu J., et al. Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J. Immunol 2008, 180:8280-8285. pmid:18523294.
101. Burdelya L.G., Krivokrysenko V.I., Tallant T.C., Strom E., Gleiberman A.S., Gupta D., et al. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 2008, 320:226-230. pmid:18403709.
102. Burdelya L.G., Brackett C.M., Kojouharov B., Gitlin I.I., Leonova K.I., Gleiberman A.S., et al. Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:E1857-E1866. pmid:23630282.
103. Ciorba M.A., Riehl T.E., Rao M.S., Moon C., Ee X., Nava G.M., et al. Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. Gut 2012, 61:829-838. pmid:22027478.
104. Talas M., Szolgay E. Radioprotective activity of interferon inducers. Arch. Virol 1978, 56:309-315. pmid:348157.
105. Shakhov A.N., Singh V.K., Bone F., Cheney A., Kononov Y., Krasnov P., et al. Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2). PLoS ONE 2012, 7. e33044. pmid:22479357.
106. Lacave-Lapalun J.V., Benderitter M., Linard C. Flagellin or lipopolysaccharide treatment modified macrophage populations after colorectal radiation of rats. J. Pharmacol. Exp. Ther 2013, 346:75-85. pmid:23596059.
107. Zhang C., Lin J., Cui J., Li B., Liu C., Wang J., et al. Radioprotection of bone marrow hematopoiesis by CpG-oligodeoxynucleotides administered to mice after total-body irradiation. J. Radiat. Res 2011, 52:828-833. pmid:22104272.
108. Kim K., Pollard J.M., Norris A.J., McDonald J.T., Sun Y., Micewicz E., et al. High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones. Clin. Cancer Res 2009, 15:7238-7245. pmid:19920105.
109. Kim K., Damoiseaux R., Norris A.J., Rivina L., Bradley K., Jung M.E., et al. High throughput screening of small molecule libraries for modifiers of radiation responses. Int. J. Radiat. Biol 2011, 87:839-845. pmid:21401317.
110. Egan L.J., Eckmann L., Greten F.R., Chae S., Li Z.W., Myhre G.M., et al. IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:2452-2457. pmid:14983030.
111. Riehl T.E., Newberry R.D., Lorenz R.G., Stenson W.F. TNFR1 mediates the radioprotective effects of lipopolysaccharide in the mouse intestine. Am. J. Physiol. Gastrointest. Liver Physiol 2004, 286:G166-G173. pmid:14525729.
112. Paun A., Fox J., Balloy V., Chignard M., Qureshi S.T., Haston C.K. Combined Tlr2 and Tlr4 deficiency increases radiation-induced pulmonary fibrosis in mice. Int. J. Radiat. Oncol. Biol. Phys 2010, 77:1198-1205. pmid:20610040.
113. McLaughlin M.M., Dacquisto M.P., Jacobus D.P., Horowitz R.E. Effects of the germfree state on responses of mice to whole-body irradiation. Radiat. Res 1964, 23:333-349. pmid:14229117.
114. Lai X.Y., Egan L.J. Suppression of radiation-induced DNA double-strand break repair by MyD88 is accompanied by apoptosis and crypt loss in mouse colon. Oncogenesis 2013, 2. e62. pmid:23939014.
115. Woo S.R., Fuertes M.B., Corrales L., Spranger S., Furdyna M.J., Leung M.Y., et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 2014, 41:830-842. pmid:25517615.
116. Deng L., Liang H., Xu M., Yang X., Burnette B., Arina A., et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type i interferon-dependent antitumor immunity in immunogenic tumors. Immunity 2014, 41:843-852. pmid:25517616.
117. Klarquist J., Hennies C.M., Lehn M.A., Reboulet R.A., Feau S., Janssen E.M. STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells. J. Immunol 2014, 193:6124-6134. pmid:25385820.
118. Wan S., Pestka S., Jubin R.G., Lyu Y.L., Tsai Y.C., Liu L.F. Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells. PLoS ONE 2012, 7. e32542. pmid:22396773.
119. Reits E.A., Hodge J.W., Herberts C.A., Groothuis T.A., Chakraborty M., Wansley E.K., et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J. Exp. Med 2006, 203:1259-1271. pmid:16636135.
120. Johnson D.R., Pober J.S. HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol. Cell. Biol 1994, 14:1322-1332. pmid:8289810.
121. Diamond M.S., Kinder M., Matsushita H., Mashayekhi M., Dunn G.P., Archambault J.M., et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J. Exp. Med 2011, 208:1989-2003. pmid:21930769.
122. Fuertes M.B., Kacha A.K., Kline J., Woo S.R., Kranz D.M., Murphy K.M., et al. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha} + dendritic cells. J. Exp. Med 2011, 208:2005-2016. pmid:21930765.
123. Schaue D., Ratikan J.A., Iwamoto K.S., McBride W.H. Maximizing tumor immunity with fractionated radiation. Int. J. Radiat. Oncol. Biol. Phys 2012, 83:1306-1310. pmid:22208977.
124. Dewan M.Z., Galloway A.E., Kawashima N., Dewyngaert J.K., Babb J.S., Formenti S.C., et al. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin. Cancer Res 2009, 15:5379-5388. pmid:19706802.
125. McBride W.H., Schaue D. Radiation biology of SBRT: is there a new biology involved?. Hypofractionation: Scientific Concepts and Clinical Experiences 2011, 3-18. LumiText Publishing, Elliot City. A. Pollack, M.M. Ahmed (Eds.).
126. Finkelstein S.E., Timmerman R., McBride W.H., Schaue D., Hoffe S.E., Mantz C.A., et al. The confluence of stereotactic ablative radiotherapy and tumor immunology. Clin. Dev. Immunol 2011, 2011. 439752. pmid:22162711.
127. Marabelle A., Filatenkov A., Sagiv-Barfi I., Kohrt H. Radiotherapy and Toll-Like Receptor Agonists. Semin. Radiat. Oncol 2015, 25:34-39. pmid:25481264.
128. Schon M.P., Schon M. Imiquimod: mode of action. Br. J. Dermatol 2007, 157(Suppl. 2):8-13. pmid:18067624.
129. Wolff F., Loipetzberger A., Gruber W., Esterbauer H., Aberger F., Frischauf A.M. Imiquimod directly inhibits Hedgehog signalling by stimulating adenosine receptor/protein kinase A-mediated GLI phosphorylation. Oncogene 2013, 32:5574-5581. pmid:23995793.
130. Milas L., Mason K.A., Ariga H., Hunter N., Neal R., Valdecanas D., et al. CpG oligodeoxynucleotide enhances tumor response to radiation. Cancer Res 2004, 64:5074-5077. pmid:15289307.
131. Brody J.D., Ai W.Z., Czerwinski D.K., Torchia J.A., Levy M., Advani R.H., et al. In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study. J. Clin. Oncol 2010, 28:4324-4332. pmid:20697067.
132. Gao C., Kozlowska A., Nechaev S., Li H., Zhang Q., Hossain D.M., et al. TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy. Cancer Res 2013, 73:7211-7221. pmid:24154870.
133. Huang B., Zhao J., Unkeless J.C., Feng Z.H., Xiong H. TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 2008, 27:218-224. pmid:18176603.
134. Cherfils-Vicini J., Platonova S., Gillard M., Laurans L., Validire P., Caliandro R., et al. Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance. J. Clin. Invest 2010, 120:1285-1297. pmid:20237413.